New hope for advanced cancer patients with HER-2 tumors
Disease control
Ongoing
This study looks at the safety of a drug called trastuzumab rezetecan, given alone or with other treatments, for people with advanced solid tumors that have the HER-2 protein. About 30 adults whose cancer has come back or spread, and who have not responded to or cannot take stand…
Sponsor: Lixiaoling • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC